<!DOCTYPE html>
<html lang="en-us">
  <head>
	<meta name="generator" content="Hugo 0.85.0" />
    <meta charset="utf-8">
    <meta name="viewport" content="width=device-width, initial-scale=1">
    
    <title>fallingstar-Daily-rss | Fallingstar Daily R</title>
    <link rel="stylesheet" href="/css/style.css" />
    <link rel="stylesheet" href="/css/fonts.css" />
    <link href="//cdn.bootcss.com/highlight.js/9.12.0/styles/github.min.css" rel="stylesheet">

  </head>

  <body>
    <nav class="header">
      <div class="banner">
<a href="/" class="text">
&Ffr;&Afr;&Lfr;&Lfr;&Ifr;&Nfr;&Gfr;&Sfr;&Tfr;&Afr;&Rfr; &Dfr;&Afr;&Ifr;&Lfr;&Yfr; &Rfr;
</a>
</div>

      <div class="head-meta">
      
        <span>fallingstar-Daily-rss</span>
        <span>2024-09-24</span>
      
      </div>
    </nav>


<div class="container">
<main class="list">

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39313795/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240924183559&amp;v=2.18.0.post9&#43;e462414">Un/met: a mixed-methods study on primary healthcare needs of the poorest population in Khyber Pakhtunkhwa province, Pakistan</a></h1>
  <div class="date-author">
    
    <span class="date">2024-09-24</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39313795-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240924183559-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    CONCLUSION: Social health protection policies can contribute to advancing UHC for primary care. However, in our setting, enhancing communication and outreach, addressing gender and age disparities, and improving quality of care and health infrastructure are necessary to fully meet the needs of the poorest &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39313814/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240924183559&amp;v=2.18.0.post9&#43;e462414">Participant observation for inquiry-based learning: a document analysis of exam papers from an internship-course for master&#39;s students in health services research in Germany</a></h1>
  <div class="date-author">
    
    <span class="date">2024-09-24</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39313814-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240924183559-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    Inquiry-based learning (IBL) is a type of problem-based learning. While IBL aims at reflecting the work of practicing researchers, only some students will pursue an academic career. We therefore designed a course that provides opportunities for IBL by applying participant observation to internship work experience inside and outside academia. Using this internship course as an example, we investigated, how master&rsquo;s students in health science executed an IBL assignment regarding the application &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39314081/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240924183559&amp;v=2.18.0.post9&#43;e462414">Sacsin levels in PBMCs: A diagnostic assay for SACS variants in peripheral blood cells - A PROSPAX study</a></h1>
  <div class="date-author">
    
    <span class="date">2024-09-24</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39314081-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240924183559-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    CONCLUSIONS: Assessing sacsin levels using PBMCs offers an easy, peripherally accessible diagnostic biomarker for ARSACS, with PBMCs being much less invasive and easier to handle than fibroblasts. Additionally, this might be a potential target-engagement blood biomarker for sacsin-increasing therapies. Â© 2024 International Parkinson and Movement Disorder &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39314768/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240924183559&amp;v=2.18.0.post9&#43;e462414">Circulating extracellular vesicles as biomarkers in the diagnosis, prognosis and therapy of cardiovascular diseases</a></h1>
  <div class="date-author">
    
    <span class="date">2024-09-24</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39314768-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240924183559-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    Cardiovascular disease (CVD) ranks among the primary contributors to worldwide mortality. Hence, the importance of constant research on new circulating biomarkers for the improvement of early diagnosis and prognostication of different CVDs and the development and refinement of therapeutic measures is critical. Extracellular vesicles (EV) have a great potential as diagnostic and prognostic markers, as they represent their parent cell by enclosing cell-specific molecules, which can differ &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39314911/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240924183559&amp;v=2.18.0.post9&#43;e462414">Hereditary and Familial Traits in Urological Cancers and Their Underlying Genes</a></h1>
  <div class="date-author">
    
    <span class="date">2024-09-24</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39314911-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240924183559-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    Early recognition of hereditary urological cancers may influence diagnostic and therapeutic decision-making, and potentially alter the fate of patients and family members. Here, we introduce readers to the current knowledge on germline genetic testing and clinical practice in prostate, bladder, renal, and testicular carcinoma. Considering all urological cancer patients, routine inquiries about familial cancer history should become a standard practice in clinical settings. If suspicion &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39315092/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240924183559&amp;v=2.18.0.post9&#43;e462414">Platinum-based chemotherapy promotes antigen presenting potential in monocytes of patients with high-grade serous ovarian carcinoma</a></h1>
  <div class="date-author">
    
    <span class="date">2024-09-24</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39315092-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240924183559-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    Ovarian cancer (OC) is the most lethal gynecologic malignancy worldwide. The major clinical challenge includes the asymptomatic state of the disease, making diagnosis possible only at advanced stages. Another OC complication is the high relapse rate and poor prognosis following the standard first-line treatment with platinum-based chemotherapy. At present, numerous clinical trials are being conducted focusing on immunotherapy in OC; nevertheless, there are still no FDA-approved &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39315114/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240924183559&amp;v=2.18.0.post9&#43;e462414">Sustained nerve growth factor-induced C-nociceptor sensitization to electrical sinusoidal stimulation in humans</a></h1>
  <div class="date-author">
    
    <span class="date">2024-09-24</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39315114-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240924183559-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    CONCLUSIONS: Exceptionally long sensitization of CM and CMi nociceptors by rhNGF, uncovered by suprathreshold electrical sinusoidal stimulation, indicates a signal transduction-independent long-lasting hyperexcitability of C-nociceptors that clinically may contribute to rhNGF-maintained chronic inflammatory &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39315155/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240924183559&amp;v=2.18.0.post9&#43;e462414">Identification of diagnostic markers and molecular clusters of cuproptosis-related genes in alcohol-related liver disease based on machine learning and experimental validation</a></h1>
  <div class="date-author">
    
    <span class="date">2024-09-24</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39315155-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240924183559-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    CONCLUSIONS: We first established a prognostic model for ALD based on 3 CRGs and robust prediction efficacy was confirmed. Our investigation contributes to a comprehensive understanding of the role of cuproptosis in ALD, presenting promising avenues for the exploration of therapeutic &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39315404/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240924183559&amp;v=2.18.0.post9&#43;e462414">Functional redundancy between glucocorticoid and mineralocorticoid receptors in mature corticotropin-releasing hormone neurons protects from obesity</a></h1>
  <div class="date-author">
    
    <span class="date">2024-09-24</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39315404-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240924183559-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    CONCLUSIONS: Our data demonstrate the functional redundancy of GRs and MRs in CRH neurons to maintain energy homeostasis and prevent obesity. Simultaneous targeting of both receptors might represent an unprecedented approach to counteract &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39315665/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240924183559&amp;v=2.18.0.post9&#43;e462414">Unravelling differential Hes1 dynamics during axis elongation of mouse embryos through single-cell tracking</a></h1>
  <div class="date-author">
    
    <span class="date">2024-09-24</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39315665-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240924183559-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    The intricate dynamics of Hes expression across diverse cell types in the developing vertebrate embryonic tail have remained elusive. To address this, we developed an endogenously tagged Hes1-Achilles mouse line, enabling precise quantification of dynamics at the single-cell resolution across various tissues. Our findings reveal striking disparities in Hes1 dynamics between presomitic mesoderm (PSM) and preneural tube (pre-NT) cells. While pre-NT cells display variable, &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39315695/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240924183559&amp;v=2.18.0.post9&#43;e462414">Are histomorphological patterns a predictor for survival in uveal melanoma patients with hepatic metastases undergoing hepatic artery infusion chemotherapy?</a></h1>
  <div class="date-author">
    
    <span class="date">2024-09-24</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39315695-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240924183559-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    CONCLUSION: Histomorphological patterns of UM metastases do not seem to be a predictor for mOS in UM patients undergoing &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39315698/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240924183559&amp;v=2.18.0.post9&#43;e462414">Chem-CRISPR/dCas9FCPF: a platform for chemically induced epigenome editing</a></h1>
  <div class="date-author">
    
    <span class="date">2024-09-24</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39315698-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240924183559-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    Epigenetic aberration is one of the major driving factors in human cancer, often leading to acquired resistance to chemotherapies. Various small molecule epigenetic modulators have been reported. Nonetheless, outcomes from animal models and clinical trials have underscored the substantial setbacks attributed to pronounced on- and off-target toxicities. To address these challenges, CRISPR/dCas9 technology is emerging as a potent tool for precise modulation of epigenetic mechanism. However, &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39315711/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240924183559&amp;v=2.18.0.post9&#43;e462414">Atrial Adaptations in Athletes Heart</a></h1>
  <div class="date-author">
    
    <span class="date">2024-09-24</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39315711-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240924183559-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    CONCLUSION: An AH is accompanied by significant enlargement of the atria as well as increased cardiac muscle &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39315857/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1Rkszs2HVZ2RHP33OibaNFew6VK-LzjJWTD4GwmLlk8B-wCceh&amp;fc=20220923065203&amp;ff=20240924183414&amp;v=2.18.0.post9&#43;e462414">Health-related quality of life in cutaneous T-cell lymphoma: A post hoc analysis of a phase 3 trial in mycosis fungoides and Sezary syndrome</a></h1>
  <div class="date-author">
    
    <span class="date">2024-09-24</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39315857-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1rkszs2hvz2rhp33oibanfew6vk-lzjjwtd4gwmllk8b-wcceh-fc-20220923065203-ff-20240924183414-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    CONCLUSIONS: The symptoms of advanced MF/SS compromise all HRQL domains. Treatment goals and therapeutic choice should be informed by individual patients' disease &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39315931/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240924183559&amp;v=2.18.0.post9&#43;e462414">Plasma biomarkers in chronic single moderate-severe traumatic brain injury</a></h1>
  <div class="date-author">
    
    <span class="date">2024-09-24</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39315931-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240924183559-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    Blood biomarkers are an emerging diagnostic and prognostic tool that reflect a range of neuropathological processes following traumatic brain injury (TBI). Their effectiveness in identifying long-term neuropathological processes after TBI is unclear. Studying biomarkers in the chronic phase is vital because elevated levels in TBI might result from distinct neuropathological mechanisms during acute and chronic phases. Here, we examine plasma biomarkers in the chronic period following TBI &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39316100/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240924183559&amp;v=2.18.0.post9&#43;e462414">Genetic diagnostics of mental health disorders in adulthood</a></h1>
  <div class="date-author">
    
    <span class="date">2024-09-24</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39316100-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240924183559-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    This review article provides insights into the role of genetic diagnostics in adult mental health disorders. The importance of genetic factors in the development of mental illnesses, from rare genetic syndromes to common complex genetic disorders, is described. Current clinical characteristics that may warrant a genetic diagnostic work-up are highlighted, including intellectual disability, autism spectrum disorders and severe psychiatric conditions with specific comorbidities, such as &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39316105/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240924183559&amp;v=2.18.0.post9&#43;e462414">Prevention in old age : AÂ missed opportunity in times of demographic change?</a></h1>
  <div class="date-author">
    
    <span class="date">2024-09-24</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39316105-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240924183559-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    No &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39316316/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240924183559&amp;v=2.18.0.post9&#43;e462414">Determinants of long-term survival in patients with IDH-mutant gliomas</a></h1>
  <div class="date-author">
    
    <span class="date">2024-09-24</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39316316-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240924183559-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    CONCLUSION: Large T2 tumor volume and contrast enhancement may be important risk factors for shorter survival, while age might be of lesser importance. Wait-and-scan strategies may yield excellent long-term survival in some patients with &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1671109627/Oyv4le00T">ð»ä»¥è²ååæ¹ï¼é»å·´å«©è¿å»çç«ç®­æµè¾¾ãð»via n12.ilæ°é»#é»å·´å«©ç»åæè¡è¥ä¸å¤©# [å¾ç][å¾ç][å¾ç][å¾ç][å¾ç][å¾ç]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-09-24</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1671109627-oyv4le00t/">
    
    
    
    
    
      
    
    ð»ä»¥è²ååæ¹ï¼é»å·´å«©è¿å»çç«ç®­æµè¾¾ã<!-- raw HTML omitted -->ð»via n12.ilæ°é»<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->#é»å·´å«©ç»åæè¡è¥ä¸å¤©#<!-- raw HTML omitted --><!-- raw HTML omitted --> <!-- raw HTML omitted -->&lt;img style=&quot;&quot; src=&ldquo;<a href="https://tvax2.sinaimg.cn/large/639b1bfbly1htz2olxn64j20dc0nk74u.j">https://tvax2.sinaimg.cn/large/639b1bfbly1htz2olxn64j20dc0nk74u.j</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1671109627/Oyv7exsYl">ð»å·æ®å¨å®¾å¤æ³å°¼äºå·å¨èå¯¹çº¦ç¿°è¿ªå°å¾æ¶ 200% çå³ç¨ãð»çº¦ç¿°è¿ªå°å¬å¸ï¼John Deere ï¼æ¯ä¸å®¶ç¾å½å¬å¸ï¼ä¸»è¦çäº§åä¸æºæ¢°ãåæ¬åç§æææºãå®å¨ 2022 å¹´ã...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-09-24</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1671109627-oyv7exsyl/">
    
    
    
    
    
      
    
    ð»å·æ®å¨å®¾å¤æ³å°¼äºå·å¨èå¯¹çº¦ç¿°è¿ªå°å¾æ¶ 200% çå³ç¨ã<!-- raw HTML omitted -->ð»çº¦ç¿°è¿ªå°å¬å¸ï¼John Deere ï¼æ¯ä¸å®¶ç¾å½å¬å¸ï¼ä¸»è¦çäº§åä¸æºæ¢°ãåæ¬åç§æææºãå®å¨ 2022 å¹´ãè´¢å¯ãç¾å½500å¼ºæå¤§å¬å¸æ¦åä¸­æåç¬¬ 84 ä½ã2024 å¹´ 7 æï¼çº¦ç¿°è¿ªå°å®£å¸å°å¨ç¾å½ä¸­è¥¿é¨å·¥åè£å 600 äººï¼å¹¶èèå°é¨åé¶é¨ä»¶ççäº§è½¬ç§»å°å¢¨è¥¿å¥ã<!-- raw HTML omitted -->ð»via vk<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->#ç­é¨è§é¢#<!-- raw HTML omitted --><!-- raw HTML omitted --> <!-- raw HTML omitted --><!-- raw HTML omitted -->&lt;img style=&ldquo;width: 1rem;height: 1rem&rdquo; src=&ldquo;<a href="https://h5.sinaimg.cn/upload/20">https://h5.sinaimg.cn/upload/20</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1671109627/OyxDsuC5H">ð»å¢å¡ç³ç§ååå½ä»¤ä»çå°åä»¬âåå¥½æäºåå¤âï¼âå¯¹é¨éç«å³å¼å§æ´é¡¿åå¤§è§æ¨¡å·¡æ¥ï¼ä½¿ä¹è¾¾å°çæ³ç¶æâï¼âä¸å¸ä¿ä½è¿åºæäºä¸ä¼åçâãð»via ç½éç¤¾#ç­...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-09-24</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1671109627-oyxdsuc5h/">
    
    
    
    
    
      
    
    ð»å¢å¡ç³ç§ååå½ä»¤ä»çå°åä»¬âåå¥½æäºåå¤âï¼âå¯¹é¨éç«å³å¼å§æ´é¡¿åå¤§è§æ¨¡å·¡æ¥ï¼ä½¿ä¹è¾¾å°çæ³ç¶æâï¼âä¸å¸ä¿ä½è¿åºæäºä¸ä¼åçâã<!-- raw HTML omitted -->ð»via ç½éç¤¾<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->#ç­é¨è§é¢#<!-- raw HTML omitted --><!-- raw HTML omitted --> <!-- raw HTML omitted --><!-- raw HTML omitted -->&lt;img style=&quot;&quot; src=&ldquo;<a href="https://tvax2.sinaimg.cn/large/639b1bfbly1htze">https://tvax2.sinaimg.cn/large/639b1bfbly1htze</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1671109627/Oyxh894gg">ð»ä»¥è²ååé¨å é»å·´å«©ç«ç®­èµ·ç«ãð»via N12.il#é»å·´å«©ç»åæè¡è¥ä¸å¤©##ç­é¨è§é¢# åå®¹ä¸ç©ææ²³æ°´çå¾®åè§é¢</a></h1>
  <div class="date-author">
    
    <span class="date">2024-09-24</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1671109627-oyxh894gg/">
    
    
    
    
    
      
    
    ð»ä»¥è²ååé¨å é»å·´å«©ç«ç®­èµ·ç«ã<!-- raw HTML omitted -->ð»via N12.il<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->#é»å·´å«©ç»åæè¡è¥ä¸å¤©#<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->#ç­é¨è§é¢#<!-- raw HTML omitted --><!-- raw HTML omitted --> &lt;a &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1671109627/OyxHr656I">è¿åå®¹çççæ¯ç¾æäº¤é - è½¬å @å°ç±å¥å¢å:&amp;ensp;æ²¡æ³å°åç¿»å¼è¿æ¬èµ åæ¯å ä¸ºasoulå·¥ä½å®¤çå®äºï¼ï¼ï¼ [å¾ç][å¾ç][å¾ç][å¾ç]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-09-24</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1671109627-oyxhr656i/">
    
    
    
    
    
      
    
    è¿åå®¹çççæ¯ç¾æäº¤é<!-- raw HTML omitted --><!-- raw HTML omitted --> - è½¬å <!-- raw HTML omitted -->@å°ç±å¥å¢å<!-- raw HTML omitted -->:âæ²¡æ³å°åç¿»å¼è¿æ¬èµ åæ¯å ä¸ºasoulå·¥ä½å®¤çå®äºï¼ï¼ï¼ <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->&lt;img style=&quot;&quot; src=&ldquo;<a href="https://tvax3.sinaimg.cn/large/007LjVbggy1htxt5r95dtj32tc240hdu.j">https://tvax3.sinaimg.cn/large/007LjVbggy1htxt5r95dtj32tc240hdu.j</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1671109627/OyxiMCM61">ð»èåå½ï¼èåå½é¾æ°ä¸ååäºå¤ä¸¤åéåå ä»¥è²åè¢­å»èå¨é»å·´å«©éé¾ã#ä»¥åç©ºè¢­å·²è´é»å·´å«©50åå¿ç«¥æ­»äº¡#</a></h1>
  <div class="date-author">
    
    <span class="date">2024-09-24</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1671109627-oyximcm61/">
    
    
    
    
    
      
    
    ð»èåå½ï¼èåå½é¾æ°ä¸ååäºå¤ä¸¤åéåå ä»¥è²åè¢­å»èå¨é»å·´å«©éé¾ã<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->#ä»¥åç©ºè¢­å·²è´é»å·´å«©50åå¿ç«¥æ­»äº¡#<!-- raw HTML omitted --><!-- raw HTML omitted -->  &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1671109627/OyxLJqSnO">ð»ä¹åå°åªä½æ­£å¨çæ¥æè´£ç½ä¿ç½æ¯ç©ºåéå-130âå¥ä¾µä¹åå°é¢ç©ºâãð»via rbc.ua [å¾ç][å¾ç]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-09-24</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1671109627-oyxljqsno/">
    
    
    
    
    
      
    
    ð»ä¹åå°åªä½æ­£å¨çæ¥æè´£ç½ä¿ç½æ¯ç©ºåéå-130âå¥ä¾µä¹åå°é¢ç©ºâã<!-- raw HTML omitted -->ð»via rbc.ua <!-- raw HTML omitted --><!-- raw HTML omitted --> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1671109627/Oyxp11vP8">ð»å¡å-å¡å°æ£®å¤§éªæ³½è¿æ¯åºï¼ð»âå®éä¸ï¼æå¹¶ä¸æ³åºç°å¨å«äººçå·éï¼æ»å»ä»ä»¬çæ¿å®¢ãä½æçå°ä¸å¼ ç§çï¼ä½ ä»¬çå·é¿ä¹å¸-å¤ç®ç½ä¸ä¸ä½å¤å½å¤´ç®ç«å¨ä¸èµ·ï¼å¨...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-09-24</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1671109627-oyxp11vp8/">
    
    
    
    
    
      
    
    ð»å¡å-å¡å°æ£®å¤§éªæ³½è¿æ¯åºï¼<!-- raw HTML omitted -->ð»âå®éä¸ï¼æå¹¶ä¸æ³åºç°å¨å«äººçå·éï¼æ»å»ä»ä»¬çæ¿å®¢ãä½æçå°ä¸å¼ ç§çï¼ä½ ä»¬çå·é¿ä¹å¸-å¤ç®ç½ä¸ä¸ä½å¤å½å¤´ç®ç«å¨ä¸èµ·ï¼å¨ä¸æç®å¼¹ä¸ç­¾å­ï¼è¿æç®å¼¹å°ç¸ æ­»ä¸ä¸ªä¸æä»¬æ²¡æäº¤æçå½å®¶çå¹³æ°ï¼èä»çè¸ä¸å´å¸¦çç¬å®¹ãæå¯¹æ­¤å¾åæï¼å®éä¸ï¼æè¢«å®æ¿æäºãâ<!-- raw HTML omitted -->ð»å°±æ¬ºè´å¸æºæ¯å§ï¼éªéªâç¸ç¸çç¸ç¸å«ç·ç·âè¯è¯ï¼ç»ä¸çæç¾å½äººçç½åè§£éä¸ä¸ï¼å¤ç®ç½å°±æ¯é£ä¸ªè¯´âå ä¸ºå·´åæ¯å¦äººå¤ªå¥½æèæ æ³å®ç°åå¹³âçäººã<!-- raw HTML omitted -->ð»via RNC news<!-- raw HTML omitted --><!-- raw HTML omitted -->&lt;span  &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1671109627/OyxpTvhdr">ï¼ æ¥çå¾ç //@huasiyangMVP:æåè®°å¾ä¸å¯é å®ä½æ¸åä»èµµç«åé£ä¼å¿è¯´å°ç°å¨ï¼ä¹æ²¡ç¡®ååå¸[ç¬cry] - è½¬å @åå®¹ä¸ç©ææ²³æ°´:&amp;ensp;ð»åå¡é¨ï¼è¿æï¼æå³æºæ...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-09-24</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1671109627-oyxptvhdr/">
    
    
    
    
    
      
    
    ï¼ <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->æ¥çå¾ç<!-- raw HTML omitted --><!-- raw HTML omitted --> //<!-- raw HTML omitted -->@huasiyangMVP<!-- raw HTML omitted -->:æåè®°å¾ä¸å¯é å®ä½æ¸åä»èµµç«åé£ä¼å¿è¯´å°ç°å¨ï¼ä¹æ²¡ç¡®ååå¸<!-- raw HTML omitted -->&lt;img alt=&quot;[ç¬cry]&quot; src=&ldquo;<a href="https://h5.sinaimg.cn/m/emoticon/icon/def">https://h5.sinaimg.cn/m/emoticon/icon/def</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1671109627/OyxvwesoI">åæä¹æ¯æï¼ä¹å¾ä¸å°é¢é¨éæä¸åºåãåé¨å åä¸äººçæ£å¿«ä¸å¹´äºï¼ä¹ç¾ä¸äººçå½å®¶æ¿åä¸èµ·äºã//@é£çå¤aab:[åæ²]ä»¥è²åä¸ºä»ä¹è¦èµ¶å¨èç¾å¤§éä¹åæäºåï¼æè§...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-09-24</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1671109627-oyxvwesoi/">
    
    
    
    
    
      
    
    åæä¹æ¯æï¼ä¹å¾ä¸å°é¢é¨éæä¸åºåãåé¨å åä¸äººçæ£å¿«ä¸å¹´äºï¼ä¹ç¾ä¸äººçå½å®¶æ¿åä¸èµ·äºã//<!-- raw HTML omitted -->@é£çå¤aab<!-- raw HTML omitted -->:<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->ä»¥è²åä¸ºä»ä¹è¦èµ¶å¨èç¾å¤§éä¹åæäºåï¼æè§ä»ä»¬å¾æ¥çæ ·å­ï¼æçè¯´å·æ®ä¸å°äºä¸æ¯æ´æ¯æä»ä»¬å<!-- raw HTML omitted --><!-- raw HTML omitted --> - è½¬å <!-- raw HTML omitted -->@åå®¹ä¸ç©ææ²³æ°´<!-- raw HTML omitted -->:âð»ä»¥è²ååé¨å é»å·´å«©ç«ç®­èµ·ç«ã<!-- raw HTML omitted -->ð»via N12.il<!-- raw HTML omitted -->&lt;a href=&ldquo;<a href="https://m.weibo.cn/search?containerid=231522type%3D1%26t%3D10%26q%3D%23%E9%25B">https://m.weibo.cn/search?containerid=231522type%3D1%26t%3D10%26q%3D%23%E9%B</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/5402554084/Oytxw33JW">ç¨äºå¿«åå¹´äº[åå]//@A_Black_Dog:å»ºè®®æ¢ææº - è½¬å @é¡¶ç­TENä½¿:&amp;ensp;ä¹ä¿å²ç»ªé#ä¹ä¿å²ç»ªéææºå# 2024.09.24 16:44ãåååãååææ­£å¨ç©ºéæ¶é´å·¥ä½ä½æ...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-09-24</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-5402554084-oytxw33jw/">
    
    
    
    
    
      
    
    ç¨äºå¿«åå¹´äº<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->//<!-- raw HTML omitted -->@A_Black_Dog<!-- raw HTML omitted -->:å»ºè®®æ¢ææº<!-- raw HTML omitted --><!-- raw HTML omitted --> - è½¬å <!-- raw HTML omitted -->@é¡¶ç­TENä½¿<!-- raw HTML omitted -->:â<!-- raw HTML omitted --><!-- raw HTML omitted -->&lt;img style=&ldquo;width: 1rem;height: &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/6015489225/Oyt2Mc18r">ä¹ä¿å²ç»ªé#shiorigram# ãçµè§è¿ç»­å§W åä½³èãè½æ¥ããè·å¾äº2024å¹´æ¥æ¬æ°é´æ¾éèçå¥ççªç»é¨é¨çµè§å§çªç»ãä¼ç§å¥ãæ­å...ï¼è½æå¹¸åæ¼è¿é¨ç¾å¥½çä½åçç...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-09-24</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-6015489225-oyt2mc18r/">
    
    
    
    
    
      
    
    <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->ä¹ä¿å²ç»ªé<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->&lt;span &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/6015489225/OytrhwCQ1">ä¹ä¿å²ç»ªé#ä¹ä¿å²ç»ªéææºå# 2024.09.24 14:30ãä»å¤©ä¹ãååååæ¯å¤©é½å¨åªåå¦åº¦è¿çè½ç¶è¢«è¿½èµ¶ï¼ä½è§å¾è¢«è¿½èµ¶ä¹å¾å¹¸ç¦çæ¥å­å³ä¾¿å¦æ­¤ä¹æ³æä½è£å¢å¥½ååªå...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-09-24</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-6015489225-oytrhwcq1/">
    
    
    
    
    
      
    
    <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->ä¹ä¿å²ç»ªé<!-- raw HTML omitted --><!-- raw HTML omitted -->&lt;a href=&ldquo;<a href="https://m.weibo.cn/search?containerid=231522type%3D1%26t%3D10%26q%3D%23%E4%B9%85%E4%BF%9D%E5%8F%B2%E7%BB%AA%E9%87%8C%E6%89%8B%E6%9C%BA%E5%8D%9A%23&amp;amp;isn">https://m.weibo.cn/search?containerid=231522type%3D1%26t%3D10%26q%3D%23%E4%B9%85%E4%BF%9D%E5%8F%B2%E7%BB%AA%E9%87%8C%E6%89%8B%E6%9C%BA%E5%8D%9A%23&amp;amp;isn</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/6015489225/Oytt3vkyC">ä¹ä¿å²ç»ªé#ä¹ä¿å²ç»ªéææºå# 2024.09.24 16:44ãåååãååææ­£å¨ç©ºéæ¶é´å·¥ä½ä½ææºçµééä½å¾å¤ªå¿«äºè¿å±å¾ä¸é¡ºå©è¯¥æä¹åå¥½ï½ï¼æ²¡å¸¦åçµå¨å</a></h1>
  <div class="date-author">
    
    <span class="date">2024-09-24</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-6015489225-oytt3vkyc/">
    
    
    
    
    
      
    
    <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->ä¹ä¿å²ç»ªé<!-- raw HTML omitted --><!-- raw HTML omitted -->&lt;a href=&ldquo;<a href="https://m.weibo.cn/search?containerid=231522type%3D1%26t%3D10%26q%3D%23%E4%B9%85%E4%BF%9D%E5%8F%B2%E7%BB%AA%E9%87%8C%E6%89%8B%E6%9C%BA%E5%8D%9A%23&amp;amp;isnewpa">https://m.weibo.cn/search?containerid=231522type%3D1%26t%3D10%26q%3D%23%E4%B9%85%E4%BF%9D%E5%8F%B2%E7%BB%AA%E9%87%8C%E6%89%8B%E6%9C%BA%E5%8D%9A%23&amp;amp;isnewpa</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/6015489225/OywpfpBVa">ä¹ä¿å²ç»ªé#shiorigram# æåå°å¤å¤©å°¾å£°çæ¥å¤ä¸æ¥ï½æ¨å¤©ç¦»å¼å·¥ä½ç°åºçæ¶åå·¥ä½äººåéäºæé¶é£âºï¸è¿æ¶å°äºéºé¦è¡èâºï¸æ¥å¤ä¸æ¥ï½ [å¾ç]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-09-24</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-6015489225-oywpfpbva/">
    
    
    
    
    
      
    
    <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->ä¹ä¿å²ç»ªé<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->#shiorigram#&lt;/s &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39308420/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240923200302&amp;v=2.18.0.post9&#43;e462414">Circulating tryptophan-kynurenine pathway metabolites are associated with all-cause mortality among patients with stage I-III colorectal cancer</a></h1>
  <div class="date-author">
    
    <span class="date">2024-09-23</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39308420-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240923200302-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    Alterations within the tryptophan-kynurenine metabolic pathway have been linked to the etiology of colorectal cancer (CRC), but the relevance of this pathway for prognostic outcomes in CRC patients needs further elucidation. Therefore, we investigated associations between circulating concentrations of tryptophan-kynurenine pathway metabolites and all-cause mortality among CRC patients. This study utilizes data from 2102 stage I-III CRC patients participating in six prospective cohorts &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39308505/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240923200302&amp;v=2.18.0.post9&#43;e462414">The past, present, and future of the brain imaging data structure (BIDS)</a></h1>
  <div class="date-author">
    
    <span class="date">2024-09-23</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39308505-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240923200302-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    The Brain Imaging Data Structure (BIDS) is a community-driven standard for the organization of data and metadata from a growing range of neuroscience modalities. This paper is meant as a history of how the standard has developed and grown over time. We outline the principles behind the project, the mechanisms by which it has been extended, and some of the challenges being addressed as it evolves. We also discuss the lessons learned through the project, with the aim of enabling researchers &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39308634/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240923200302&amp;v=2.18.0.post9&#43;e462414">Validation of different automated segmentation models for target volume contouring in postoperative radiotherapy for breast cancer and regional nodal irradiation</a></h1>
  <div class="date-author">
    
    <span class="date">2024-09-23</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39308634-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240923200302-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    CONCLUSION: Artificial intelligence-based auto-segmentation programs showed high-quality accuracy and provided standardization and efficient support for guideline-based target volume contouring as a precondition for fully automated workflows in radiotherapy treatment &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39309033/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240923200302&amp;v=2.18.0.post9&#43;e462414">Searches for new physics below twice the electron mass with GERDA</a></h1>
  <div class="date-author">
    
    <span class="date">2024-09-23</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39309033-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240923200302-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    A search for full energy depositions from bosonic keV-scale dark matter candidates of masses between 65 and 1021 keV has been performed with data collected during Phase II of the GERmanium Detector Array (Gerda) experiment. Our analysis includes direct dark matter absorption as well as dark Compton scattering. With a total exposure of 105.5 kg years, no evidence for a signal above the background has been observed. The resulting exclusion limits deduced with either Bayesian or &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39309618/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240923200302&amp;v=2.18.0.post9&#43;e462414">ALKTERNATE: A Pilot Study Alternating Lorlatinib With Crizotinib in ALK-Positive NSCLC With Prior ALK Inhibitor Resistance</a></h1>
  <div class="date-author">
    
    <span class="date">2024-09-23</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39309618-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240923200302-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    CONCLUSIONS: ALKTERNATE revealed feasibility with a novel alternating ALK inhibitor strategy in ALK-positive NSCLC. Results support progressing inquiry into this approach and propose a flexible design with drug(s) selected and alternating time frames, informed by real-time plasma profiling. Moving this concept to treatment naive may also optimize &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39309700/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240923200302&amp;v=2.18.0.post9&#43;e462414">Individual-level determinants of breast and cervical cancer screening and early testing in two regionally representative urban Indian populations</a></h1>
  <div class="date-author">
    
    <span class="date">2024-09-23</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39309700-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240923200302-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    CONCLUSION: Our findings may have important implications for interventions at community-level (e.g., reducing &lsquo;fear-of-judgement&rsquo;, increasing awareness to screening programs and early symptoms) and health-system level (e.g., opportunistic &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39310222/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240923200302&amp;v=2.18.0.post9&#43;e462414">Optimising inter-patient image registration for image-based data mining in breast radiotherapy</a></h1>
  <div class="date-author">
    
    <span class="date">2024-09-23</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39310222-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240923200302-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    CONCLUSIONS: B-spline algorithm using NMI and registered supine and prone cohorts independently provides the most optimal spatial normalisation strategy for breast &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39310358/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240923200302&amp;v=2.18.0.post9&#43;e462414">Surgical Outcomes and Sociodemographic Disparities Across All Races: An ACS-NSQIP and NHIS Multi-Institutional Analysis of Over 7.5 Million Patients</a></h1>
  <div class="date-author">
    
    <span class="date">2024-09-23</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39310358-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240923200302-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    CONCLUSIONS: Our study underscores racial disparities in surgical outcomes. Focused investigations into these complications could reveal underlying causes, informing healthcare policies to enhance surgical care &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39310744/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240923200302&amp;v=2.18.0.post9&#43;e462414">Analytical performance evaluation of a new integrated clinical chemistry and immunoassay analyzer</a></h1>
  <div class="date-author">
    
    <span class="date">2024-09-23</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39310744-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240923200302-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    CONCLUSION: This is the first reported evaluation of the Atellica CI Analyzer in a clinical laboratory setting. The strong analytical performance of the Atellica CI Analyzer demonstrates that this instrument is suitable for routine clinical &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39310847/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240923200302&amp;v=2.18.0.post9&#43;e462414">Region of interest localization, tissue storage time, and antibody binding density-a technical note on the GeoMxÂ® Digital Spatial Profiler</a></h1>
  <div class="date-author">
    
    <span class="date">2024-09-23</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39310847-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240923200302-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    CONCLUSIONS: The NanoString GeoMxÂ® DSP platform delivers robust data to interrogate tumor heterogeneity, but tissue storage time should be considered when interpreting the &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39311030/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240923200302&amp;v=2.18.0.post9&#43;e462414">Time-resolved photoelectron diffraction imaging of methanol photodissociation involving molecular hydrogen ejection</a></h1>
  <div class="date-author">
    
    <span class="date">2024-09-23</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39311030-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240923200302-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    Imaging ultrafast atomic and molecular hydrogen motion with femtosecond time resolution is a challenge for ultrafast spectroscopy due to the low mass and small scattering cross section of the moving neutral hydrogen atoms and molecules. Here, we propose time- and momentum-resolved photoelectron diffraction (TMR-PED) as a way to overcome limitations of existing methodologies and illustrate its performance using a prototype molecular dissociation process involving the sequential ejection of &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39311051/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240923200302&amp;v=2.18.0.post9&#43;e462414">Is tumour sequencing effective for the identification of germline &lt;em&gt;BRCA1/2&lt;/em&gt; pathogenic variant carriers?</a></h1>
  <div class="date-author">
    
    <span class="date">2024-09-23</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39311051-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240923200302-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    CONCLUSIONS: In our tumour-to-germline testing approach, we observed the BRCA1/2 pathogenic variant frequency reported in other large unselected ovarian cancer cohorts, thus confirming its effectiveness in identifying putative germline carriers irrespective of eligibility for germline testing. As the range of tumours subjected to genetic testing broadens, this approach is expected to also be effective in other tumour settings for enhancing the identification of carriers, reducing the burden &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39311115/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1LIK-026Y9bjRE4xDQ231BSa89BnY4O2Rfi-9WXQd8C31C6cqE&amp;fc=20211015124055&amp;ff=20240923200249&amp;v=2.18.0.post9&#43;e462414">Accessible Weight Scales and Exam Tables - New Federal Regulations</a></h1>
  <div class="date-author">
    
    <span class="date">2024-09-23</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39311115-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1lik-026y9bjre4xdq231bsa89bny4o2rfi-9wxqd8c31c6cqe-fc-20211015124055-ff-20240923200249-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    No &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39311115/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1LIK-026Y9bjRE4xDQ231BSa89BnY4O2Rfi-9WXQd8C31C6cqE&amp;fc=20211015124055&amp;ff=20240924183413&amp;v=2.18.0.post9&#43;e462414">Accessible Weight Scales and Exam Tables - New Federal Regulations</a></h1>
  <div class="date-author">
    
    <span class="date">2024-09-23</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39311115-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1lik-026y9bjre4xdq231bsa89bny4o2rfi-9wxqd8c31c6cqe-fc-20211015124055-ff-20240924183413-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    No &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39311116/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1LIK-026Y9bjRE4xDQ231BSa89BnY4O2Rfi-9WXQd8C31C6cqE&amp;fc=20211015124055&amp;ff=20240923200249&amp;v=2.18.0.post9&#43;e462414">The Role of Physicians on Ethics Committees after &lt;em&gt;Dobbs&lt;/em&gt;</a></h1>
  <div class="date-author">
    
    <span class="date">2024-09-23</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39311116-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1lik-026y9bjre4xdq231bsa89bny4o2rfi-9wxqd8c31c6cqe-fc-20211015124055-ff-20240923200249-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    No &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39311116/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1LIK-026Y9bjRE4xDQ231BSa89BnY4O2Rfi-9WXQd8C31C6cqE&amp;fc=20211015124055&amp;ff=20240924183413&amp;v=2.18.0.post9&#43;e462414">The Role of Physicians on Ethics Committees after &lt;em&gt;Dobbs&lt;/em&gt;</a></h1>
  <div class="date-author">
    
    <span class="date">2024-09-23</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39311116-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1lik-026y9bjre4xdq231bsa89bny4o2rfi-9wxqd8c31c6cqe-fc-20211015124055-ff-20240924183413-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    No &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39311134/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1LIK-026Y9bjRE4xDQ231BSa89BnY4O2Rfi-9WXQd8C31C6cqE&amp;fc=20211015124055&amp;ff=20240923200249&amp;v=2.18.0.post9&#43;e462414">&lt;em&gt;Dobbs&lt;/em&gt; Revisited - Addressing Effects on Resident Training in Obstetrics and Gynecology</a></h1>
  <div class="date-author">
    
    <span class="date">2024-09-23</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39311134-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1lik-026y9bjre4xdq231bsa89bny4o2rfi-9wxqd8c31c6cqe-fc-20211015124055-ff-20240923200249-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    No &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39311134/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1LIK-026Y9bjRE4xDQ231BSa89BnY4O2Rfi-9WXQd8C31C6cqE&amp;fc=20211015124055&amp;ff=20240924183413&amp;v=2.18.0.post9&#43;e462414">&lt;em&gt;Dobbs&lt;/em&gt; Revisited - Addressing Effects on Resident Training in Obstetrics and Gynecology</a></h1>
  <div class="date-author">
    
    <span class="date">2024-09-23</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39311134-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1lik-026y9bjre4xdq231bsa89bny4o2rfi-9wxqd8c31c6cqe-fc-20211015124055-ff-20240924183413-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    No &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39311216/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240923200302&amp;v=2.18.0.post9&#43;e462414">Indications for testosterone therapy in men</a></h1>
  <div class="date-author">
    
    <span class="date">2024-09-23</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39311216-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240923200302-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    PURPOSE OF REVIEW: Testosterone replacement therapy for men with organic hypogonadism due to medical disease of the hypothalamic-pituitary-testicular (HPT) axis is uncontroversial. In these men, testosterone replacement replaces the deficient hormone and relieves the signs and symptoms of androgen deficiency. In contrast, the role of testosterone treatment in middle-aged or older men who have clinical features consistent with androgen deficiency accompanied by reductions in serum &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39311249/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1LIK-026Y9bjRE4xDQ231BSa89BnY4O2Rfi-9WXQd8C31C6cqE&amp;fc=20211015124055&amp;ff=20240923200249&amp;v=2.18.0.post9&#43;e462414">Button-Battery Ingestion</a></h1>
  <div class="date-author">
    
    <span class="date">2024-09-23</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39311249-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1lik-026y9bjre4xdq231bsa89bny4o2rfi-9wxqd8c31c6cqe-fc-20211015124055-ff-20240923200249-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    No &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39311249/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1LIK-026Y9bjRE4xDQ231BSa89BnY4O2Rfi-9WXQd8C31C6cqE&amp;fc=20211015124055&amp;ff=20240924183413&amp;v=2.18.0.post9&#43;e462414">Button-Battery Ingestion</a></h1>
  <div class="date-author">
    
    <span class="date">2024-09-23</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39311249-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1lik-026y9bjre4xdq231bsa89bny4o2rfi-9wxqd8c31c6cqe-fc-20211015124055-ff-20240924183413-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    No &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39311354/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240923200302&amp;v=2.18.0.post9&#43;e462414">Risk Factors and Preventive Measures for Lung Cancer in the European Union</a></h1>
  <div class="date-author">
    
    <span class="date">2024-09-23</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39311354-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240923200302-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    CONCLUSION: Lung cancer is a significant global health challenge. The study identified potential strategies for reducing the mortality rate from lung cancer. These strategies include an increase in the number of physicians, enhanced accessibility to cutting-edge antineoplastic medications, and state-funded coverage of the associated costs. It would be beneficial for politicians to consider implementing LDCT screening for the early detection of the disease. The implementation of &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39311364/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240923200302&amp;v=2.18.0.post9&#43;e462414">Wilson and Jungner Revisited: Are Screening Criteria Fit for the 21st Century?</a></h1>
  <div class="date-author">
    
    <span class="date">2024-09-23</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39311364-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240923200302-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    Driven by technological innovations, newborn screening (NBS) panels have been expanded and the development of genomic NBS pilot programs is rapidly progressing. Decisions on disease selection for NBS are still based on the Wilson and Jungner (WJ) criteria published in 1968. Despite this uniform reference, interpretation of the WJ criteria and actual disease selection for NBS programs are highly variable. A systematic literature search [PubMED search &ldquo;Wilson&rdquo; AND &ldquo;Jungner&rdquo;; last search &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39311774/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240923200302&amp;v=2.18.0.post9&#43;e462414">Telerehabilitation Compared to Center-based Pulmonary Rehabilitation for People with Chronic Respiratory Disease: Economic Analysis of a Randomized, Controlled Clinical Trial</a></h1>
  <div class="date-author">
    
    <span class="date">2024-09-23</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39311774-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240923200302-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    RATIONALE: New pulmonary rehabilitation models can improve access to this effective but underutilised treatment for people with chronic respiratory disease, however cost effectiveness has not been &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39311864/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240923200302&amp;v=2.18.0.post9&#43;e462414">Validation of the Late-Life Function and Disability Instrument in People Living with COPD</a></h1>
  <div class="date-author">
    
    <span class="date">2024-09-23</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39311864-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240923200302-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    CONCLUSION: The LLFDI, a valid patient-reported outcome to investigate disability and function, has proven good construct validity in people with &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39311911/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240923200302&amp;v=2.18.0.post9&#43;e462414">Single-cell transcriptomics reveal distinctive patterns of fibroblast activation in heart failure with preserved ejection fraction</a></h1>
  <div class="date-author">
    
    <span class="date">2024-09-23</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39311911-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240923200302-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    Inflammation, fibrosis and metabolic stress critically promote heart failure with preserved ejection fraction (HFpEF). Exposure to high-fat diet and nitric oxide synthase inhibitor N[w]-nitro-l-arginine methyl ester (L-NAME) recapitulate features of HFpEF in mice. To identify disease-specific traits during adverse remodeling, we profiled interstitial cells in early murine HFpEF using single-cell RNAseq (scRNAseq). Diastolic dysfunction and perivascular fibrosis were accompanied by an &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39312093/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240923200302&amp;v=2.18.0.post9&#43;e462414">Correction: Prevention at home in older persons with (pre-)frailty: analysis of participants&#39; recruitment and characteristics of the randomized controlled PromeTheus trial</a></h1>
  <div class="date-author">
    
    <span class="date">2024-09-23</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39312093-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240923200302-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    No &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39312195/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1Rkszs2HVZ2RHP33OibaNFew6VK-LzjJWTD4GwmLlk8B-wCceh&amp;fc=20220923065203&amp;ff=20240923200250&amp;v=2.18.0.post9&#43;e462414">Selective Enhancer Gain of Function Deregulates MYC Expression in Multiple Myeloma</a></h1>
  <div class="date-author">
    
    <span class="date">2024-09-23</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39312195-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1rkszs2hvz2rhp33oibanfew6vk-lzjjwtd4gwmllk8b-wcceh-fc-20220923065203-ff-20240923200250-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    MYC deregulation occurs in the majority of multiple myeloma (MM) cases and is associated with progression and worse prognosis. Enhanced MYC expression occurs in about 70% of MM patients, but it is known to be driven by translocation or amplification events in only ~40% of myelomas. Here, we used CRISPR interference (CRISPRi) to uncover an epigenetic mechanism of MYC regulation whereby increased accessibility of a plasma cell-type specific enhancer leads to increased MYC expression. This &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39312195/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1Rkszs2HVZ2RHP33OibaNFew6VK-LzjJWTD4GwmLlk8B-wCceh&amp;fc=20220923065203&amp;ff=20240924183414&amp;v=2.18.0.post9&#43;e462414">Selective Enhancer Gain of Function Deregulates MYC Expression in Multiple Myeloma</a></h1>
  <div class="date-author">
    
    <span class="date">2024-09-23</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39312195-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1rkszs2hvz2rhp33oibanfew6vk-lzjjwtd4gwmllk8b-wcceh-fc-20220923065203-ff-20240924183414-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    MYC deregulation occurs in the majority of multiple myeloma (MM) cases and is associated with progression and worse prognosis. Enhanced MYC expression occurs in about 70% of MM patients, but it is known to be driven by translocation or amplification events in only ~40% of myelomas. Here, we used CRISPR interference (CRISPRi) to uncover an epigenetic mechanism of MYC regulation whereby increased accessibility of a plasma cell-type specific enhancer leads to increased MYC expression. This &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39312541/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240923200302&amp;v=2.18.0.post9&#43;e462414">Effect of impaired kidney function on outcomes and treatment effects of oral anticoagulant regimes in patients with atrial fibrillation in a real-world registry</a></h1>
  <div class="date-author">
    
    <span class="date">2024-09-23</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39312541-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240923200302-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    CONCLUSION: Findings from our large real-life registry confirm the data from RCTs and extend our knowledge on the effectiveness and safety of DOACs to subjects that were underrepresented in &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39313641/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240924183559&amp;v=2.18.0.post9&#43;e462414">Bone support correlation of X-Ray and CT for a new PE-glenoid</a></h1>
  <div class="date-author">
    
    <span class="date">2024-09-23</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39313641-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240924183559-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    CONCLUSION: Standard true a. p. projections are reliable in ruling out gaps when no RLL or DL is visible and the detection of RLL shows high intermodal agreement. Varying agreement across tilting angles emphasizes the importance of a comprehensive approach in evaluating bone support and CT is indispensable for a scientifically reliable &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39313675/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240924183559&amp;v=2.18.0.post9&#43;e462414">Effects of intranasal oxytocin on fear extinction learning</a></h1>
  <div class="date-author">
    
    <span class="date">2024-09-23</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39313675-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240924183559-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    Once a threat no longer exists, extinction of conditioned fear becomes adaptive in order to reduce allotted resources towards cues that no longer predict the threat. In anxiety and stress disorders, fear extinction learning may be affected. Animal findings suggest that the administration of oxytocin (OT) modulates extinction learning in a timepoint-dependent manner, facilitating extinction when administered prior to fear conditioning, but impairing it when administered prior to &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39313724/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240924183559&amp;v=2.18.0.post9&#43;e462414">AI-driven biology: rethinking experiments and computation : An interview with Michael Bronstein, DeepMind Professor of Artificial Intelligence at the University of Oxford and Founding Scientific Director of the Aithyra Institute of the Austrian Academy of Sciences</a></h1>
  <div class="date-author">
    
    <span class="date">2024-09-23</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39313724-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240924183559-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    No &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1251560221/Oyh4uaRSV">å¾å¤äººå¨ç§ä¿¡éé®å¦ä½ä¿è¯æ¯å¤©å£æä¸æ¬¡å¿å¦¥ç»´çä¾ä»æ§ãå¶å®ä¸åæ¯HIVæçæ¯è¯ï¼æç¨å¶ä»æ§å¶æ¢æ§ç¾çè¯ç©å¦éåè¯ãéç³è¯åè°è¡èè¯ä¹éè¦ä¿è¯è¯å¥½ä¾ä»æ§ãæ...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-09-23</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1251560221-oyh4uarsv/">
    
    
    
    
    
      
    
    å¾å¤äººå¨ç§ä¿¡éé®å¦ä½ä¿è¯æ¯å¤©å£æä¸æ¬¡å¿å¦¥ç»´çä¾ä»æ§ãå¶å®ä¸åæ¯HIVæçæ¯è¯ï¼æç¨å¶ä»æ§å¶æ¢æ§ç¾çè¯ç©å¦éåè¯ãéç³è¯åè°è¡èè¯ä¹éè¦ä¿è¯è¯å¥½ä¾ä»æ§ãææè¿å·¥ä½ä¸­å°±éè¦åææ£èçä¾ä»æ§æ°æ®ï¼å¶å®å¨ä¸´åºä¸ï¼å»ççæµæ£èä¾ä»æ§ä¹æ¯è®©æ£èæ°è¯ç¶ä¸­çè¯ç©æ°éï¼ä»¥æ­¤æ¥çæµæ£èä¾ä»æ§ãè¿éé¤äºæ¯å¤©æè¯çæ¶åä¸é¹éä»¥å¤ï¼è¿æä¸ä¸ªå¾å¥½çæ¹æ³å°±æ¯å®æ¶ç»è®¡ï¼ç°å¨æå¾å¤æè¯Appå¯ä»¥å¸®å©æ£èçæµä¾ä»æ§ï¼è¿äºAppææ¯å¤©æéåè½ï¼ä¹æè¯ç©æ°éçæµåè½ãé¤æ­¤ä»¥å¤ï¼ä¸ä¸ªå¾å¥½çåæ³æ¯å¯ä»¥å»ºç«ä¸ä¸ªexcelè¡¨æ ¼ï¼å¨æ¯ä¸æ®µæ¶é´ï¼æ´æ°è¯ç¶éçè¯ç©æ°éï¼ä»¥æ­¤æ¥çæµä¾ä»æ§ãå¦æä»å¤©å¿è®°èªå·±æ¯å¦æè¯ï¼å¯ä»¥çè¡¨æ ¼ä¸­è¯çæ°éåèªå·±å®éè¯ç¶æ°éä¸­æ¯å¦æå·® &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1671109627/OynLRkMnT">æä¸ç¥éä½ ä»¬ä¸ºä»ä¹èå·å·ä»ä¹æå»ºå¶ç¾å½æ¢ç®ä»ä¹çâ¦â¦æ³è±¡ä¸åºé ç¾åçæåä½ç³»ååäºçºªå¾æä¹æ¯æä½ ä»¬è¿æ ·çæ³æ³ã//@æè¾¹ä¸¤æ¡æ²³:ä»¥è²åå·å·äºé£ä¹é¿æ¶é´çå...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-09-23</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1671109627-oynlrkmnt/">
    
    
    
    
    
      
    
    æä¸ç¥éä½ ä»¬ä¸ºä»ä¹èå·å·ä»ä¹æå»ºå¶ç¾å½æ¢ç®ä»ä¹çâ¦â¦æ³è±¡ä¸åºé ç¾åçæåä½ç³»ååäºçºªå¾æä¹æ¯æä½ ä»¬è¿æ ·çæ³æ³ã//<!-- raw HTML omitted -->@æè¾¹ä¸¤æ¡æ²³<!-- raw HTML omitted -->:ä»¥è²åå·å·äºé£ä¹é¿æ¶é´çåä¼ï¼ä¸ç´æå°ç°å¨æè¡å¨ï¼èåè¯å®æé´è°çï¼ä¸æ¹é¢æ¯éå¯¹é»å·´å«©çä¿¡æ¯æéåææè¡å¨ãå¦ä¸æåå¤ææå¯è½æ¯è·ç¾å½çæ¢ç®é¨éå¨è¿è¡èåä½æè®­ç»ï¼åæ¥ä¸ä¸ªå¸çäººåä¸ç«ååï¼ç°å¨æå¯è½åæä¸ä¸ªéå¢å<!-- raw HTML omitted --><!-- raw HTML omitted --> - è½¬å <!-- raw HTML omitted -->@åå®¹ä¸ç©ææ²³æ°´<!-- raw HTML omitted -->:âð»ä»¥è²åå½é²åæ»åè°é¿èµ«å°é½Â·ååç»´ä¸­å°è¡¨ç¤ºï¼âä»¥è²ååæ¹æ­£å¨ç¦è§£çä¸»å 20 å¹´æ¥å»ºç«èµ·æ¥çè½åãâ<!-- raw HTML omitted -->ð»â¦â¦ä¸æ¯ï¼ä½ è¿åé»ä¸å«çº¿çº§å«çå°ä¸å·¥äºç¾¤è¾¹é½æ²¡æ¨çï¼æè¿å¿å¹çæ¹å¯è¿è¡ï¼éªäººéªå·±ï¼è½éªå¾äºæä»¬ä¸äºæªç©æ¿ä¹ï¼<!-- raw HTML omitted -->ð»via &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1671109627/Oyo5wf6pG">ð»ç°å¨æ²¡æç¡çåå æ¯ä¸è¾¹å·é»ä»¥å¯¹è½°ï¼ä¸è¾¹å·ææ¼«ç»å·¥ä½å®¤åå·¥ååå·¥å¯¹è½°[åå¦Aæ¢¦åæ]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-09-23</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1671109627-oyo5wf6pg/">
    
    
    
    
    
      
    
    ð»ç°å¨æ²¡æç¡çåå æ¯ä¸è¾¹å·é»ä»¥å¯¹è½°ï¼ä¸è¾¹å·ææ¼«ç»å·¥ä½å®¤åå·¥ååå·¥å¯¹è½°<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->  &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1671109627/Oyo9Cmr5H">ð»#æä¹é¸å·¥ä½å®¤#è¿çåçæç¡æå¨æ [åå¦Aæ¢¦åæ]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-09-23</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1671109627-oyo9cmr5h/">
    
    
    
    
    
      
    
    ð»<!-- raw HTML omitted --><!-- raw HTML omitted -->#æä¹é¸å·¥ä½å®¤#<!-- raw HTML omitted --><!-- raw HTML omitted -->è¿çåçæç¡æå¨æ <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->  &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1671109627/Oyoa6dbCn">é»å·´å«©al-mãå¡å¡å°ajaãè·¯éç¤¾ãä»¥è²åæ¶æ¥åæ°æ¶æ¯æ¥è¿å å®¶åªä½å®ç½é½å¼äºæ°é»liveæ¨¡å¼ã//@Astanian:å¨ ä»ä¹ç½ç«å·é»å·´å«©ä»¥è²åå¯¹è½°çåï¼ - è½¬å @åå®¹ä¸ç©...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-09-23</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1671109627-oyoa6dbcn/">
    
    
    
    
    
      
    
    é»å·´å«©al-mãå¡å¡å°ajaãè·¯éç¤¾ãä»¥è²åæ¶æ¥åæ°æ¶æ¯æ¥è¿å å®¶åªä½å®ç½é½å¼äºæ°é»liveæ¨¡å¼ã//<!-- raw HTML omitted -->@Astanian<!-- raw HTML omitted -->:å¨ ä»ä¹ç½ç«å·é»å·´å«©ä»¥è²åå¯¹è½°çåï¼<!-- raw HTML omitted --><!-- raw HTML omitted --> - è½¬å <!-- raw HTML omitted -->@åå®¹ä¸ç©ææ²³æ°´<!-- raw HTML omitted -->:âð»ç°å¨æ²¡æç¡çåå æ¯ä¸è¾¹å·é»ä»¥å¯¹è½°ï¼ä¸è¾¹å·ææ¼«ç»å·¥ä½å®¤åå·¥ååå·¥å¯¹è½°<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1671109627/Oyoe27Q8G">ð»ç®åå°±çå°@æä¹é¸-ç±ç»ç» åå¦ä¸ä½åºæ¥ååºäºä¸å¤§å ãð»å¦å¤ä¸è¾¹åä¸å£°è®¨çååå·¥ä¹æä¸å°ãð»æä¹è®²â¦â¦è¿çåçå¿ææç¹å¤æ[åå¦Aæ¢¦åæ]ã#æä¹é¸...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-09-23</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1671109627-oyoe27q8g/">
    
    
    
    
    
      
    
    ð»ç®åå°±çå°<!-- raw HTML omitted -->@æä¹é¸-ç±ç»ç»<!-- raw HTML omitted --> åå¦ä¸ä½åºæ¥ååºäºä¸å¤§å ã<!-- raw HTML omitted -->ð»å¦å¤ä¸è¾¹åä¸å£°è®¨çååå·¥ä¹æä¸å°ã<!-- raw HTML omitted -->ð»æä¹è®²â¦â¦è¿çåçå¿ææç¹å¤æ<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->ã<!-- raw HTML omitted -->&lt;a href=&ldquo;<a href="https://m.weibo.cn/search?containerid=231522type%3D1%26t%3D10%26q%3D%23%E6%9E%81%E4%B9%90%E9%B8%9F%E5%B7%A5%E4%BD%9C%E5%AE%A4%23&amp;amp;extparam=%23%E6%9E%81%E4%B9%90%E9%B8%9F%E5">https://m.weibo.cn/search?containerid=231522type%3D1%26t%3D10%26q%3D%23%E6%9E%81%E4%B9%90%E9%B8%9F%E5%B7%A5%E4%BD%9C%E5%AE%A4%23&amp;amp;extparam=%23%E6%9E%81%E4%B9%90%E9%B8%9F%E5</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1671109627/Oyokehgc5">ð»ä¸ºäºæ¹ä¾¿å¤§å®¶åå¤åçï¼ææå ä¸ªå½äºäººæéè¦çå æ¡å¾®åæ´åå¨è¿éï¼ð»@ç-æ³å ¡ çå³é®å ç¯å¨å¾1-å¾4ð»@A-soulé©è¶ çååºå¨å¾5-7ð»@æä¹é¸-ç±ç»ç» ç...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-09-23</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1671109627-oyokehgc5/">
    
    
    
    
    
      
    
    ð»ä¸ºäºæ¹ä¾¿å¤§å®¶åå¤åçï¼ææå ä¸ªå½äºäººæéè¦çå æ¡å¾®åæ´åå¨è¿éï¼<!-- raw HTML omitted -->ð»<!-- raw HTML omitted -->@ç-æ³å ¡<!-- raw HTML omitted --> çå³é®å ç¯å¨å¾1-å¾4<!-- raw HTML omitted -->ð»<!-- raw HTML omitted -->@A-soulé©è¶<!-- raw HTML omitted --> çååºå¨å¾5-7<!-- raw HTML omitted -->ð»<!-- raw HTML omitted -->@æä¹é¸-ç±ç»ç»<!-- raw HTML omitted --> çååºå¨å¾8<!-- raw HTML omitted -->ð»<!-- raw HTML omitted -->@æ¶è­çé²<!-- raw HTML omitted --> çååºå¨å¾9<!-- raw HTML omitted -->ð»è¿æä¸äºååå·¥çåè¨å¨ç¸å³å¾®åè¯è®ºåº<!-- raw HTML omitted -->ð»ä½ä¸ºè·¯äººï¼æçå®ä¹åä»ä¸ç¥è°å¯¹è°éï¼ä½ä¸ºA-soulè¯¸å¤ä½ååä¸­å½å½äº§æ¼«ç»ä»ç»çæ¶ä»£å°±ä¸å¦æ¢å¾æ¯æãå³æ³¨çè¯»èï¼æçå®ä¹åå¿æå¤æã<!-- raw HTML omitted -->ð»è¿ä¸ªå¤æä¸ä»ä»æ¯å ä¸ºè¿ä¸ªççï¼è¿æå³äºè¿ä¸ªè¡ä¸çç§äºä¸ç¥éå¤å°äººçç­ç±åéæ¥çã<!-- raw HTML omitted --> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1671109627/OyomUBIAl">ð»æä¸ç¥éè¿ä¸ªæ¯å»å¯¹ä¸å¯¹ãå°±æä¸ç¹ç¹åçäºé»æ¡çæè§ã#æä¹é¸å·¥ä½å®¤#</a></h1>
  <div class="date-author">
    
    <span class="date">2024-09-23</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1671109627-oyomubial/">
    
    
    
    
    
      
    
    ð»æä¸ç¥éè¿ä¸ªæ¯å»å¯¹ä¸å¯¹ãå°±æä¸ç¹ç¹åçäºé»æ¡çæè§ã<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->#æä¹é¸å·¥ä½å®¤#<!-- raw HTML omitted --><!-- raw HTML omitted -->  &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1671109627/Oyop30OPa">é®çå¥½ï¼è¿ä¸ªè¡ä¸çæ æ°åºæé¼ï¼å¤§é½æºäºæ­¤//@æ¡å­å±å±å°é¦å¤´:è¿ä¸ªè¡ä¸çç§äºä¸ç¥éå¤å°äººçç­ç±åéæ¥ï¼æ¢å¾å©çèå°åºæ¯è°å¢ - è½¬å @åå®¹ä¸ç©ææ²³æ°´:&amp;ensp;ï¿½...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-09-23</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1671109627-oyop30opa/">
    
    
    
    
    
      
    
    é®çå¥½ï¼è¿ä¸ªè¡ä¸çæ æ°åºæé¼ï¼å¤§é½æºäºæ­¤//<!-- raw HTML omitted -->@æ¡å­å±å±å°é¦å¤´<!-- raw HTML omitted -->:è¿ä¸ªè¡ä¸çç§äºä¸ç¥éå¤å°äººçç­ç±åéæ¥ï¼æ¢å¾å©çèå°åºæ¯è°å¢<!-- raw HTML omitted --><!-- raw HTML omitted --> - è½¬å <!-- raw HTML omitted -->@åå®¹ä¸ç©ææ²³æ°´<!-- raw HTML omitted -->:âð»ä¸ºäºæ¹ä¾¿å¤§å®¶åå¤åçï¼ææå ä¸ªå½äºäººæéè¦çå æ¡å¾®åæ´åå¨è¿éï¼<!-- raw HTML omitted -->ð»<!-- raw HTML omitted -->@ç-æ³å ¡<!-- raw HTML omitted --> çå³é®å ç¯å¨å¾1-å¾4<!-- raw HTML omitted -->ð»<!-- raw HTML omitted -->@A-soulé©è¶<!-- raw HTML omitted --> çååºå¨å¾5-7<!-- raw HTML omitted -->ð»&lt;a href=&ldquo;<a href="https://weibo.com/n/%E6%9E%81%E4%B9%90%E9%B8%9F-%E7%88%B1%E7%94%BB%25E">https://weibo.com/n/%E6%9E%81%E4%B9%90%E9%B8%9F-%E7%88%B1%E7%94%BB%E</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1671109627/OyosKAop0">ð»æ¾ç»ï¼wowçé¦æå¢å¥½åä¹åºè¿ç±»ä¼¼çäºæâ¦â¦ð»æå¯¹é£ä¸ªå°éä¸çå·¥ä½å®¤ä¹è®°å¿ç¹æ°ã#æä¹é¸å·¥ä½å®¤#</a></h1>
  <div class="date-author">
    
    <span class="date">2024-09-23</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1671109627-oyoskaop0/">
    
    
    
    
    
      
    
    ð»æ¾ç»ï¼wowçé¦æå¢å¥½åä¹åºè¿ç±»ä¼¼çäºæâ¦â¦<!-- raw HTML omitted -->ð»æå¯¹é£ä¸ªå°éä¸çå·¥ä½å®¤ä¹è®°å¿ç¹æ°ã<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->#æä¹é¸å·¥ä½å®¤#<!-- raw HTML omitted --><!-- raw HTML omitted -->  &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1671109627/Oyph9p4Ns">ð»é»å·´å«©å«çé¨ï¼ä»¥åå½å¤©å¯¹é»å·´å«©å¤å°åå¨ç©ºè¢­é æçæ­» äº¡äººæ°åè³492äººï¼å¦æ1645äººåä¼¤ãð»å¾ä¸ºé»å·´å«©åªä½å¬å¸çé¨åé é¾ èã#ä»¥åç©ºè¢­é»å·´å«©å¤å°è´275...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-09-23</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1671109627-oyph9p4ns/">
    
    
    
    
    
      
    
    ð»é»å·´å«©å«çé¨ï¼ä»¥åå½å¤©å¯¹é»å·´å«©å¤å°åå¨ç©ºè¢­é æçæ­» äº¡äººæ°åè³492äººï¼å¦æ1645äººåä¼¤ã<!-- raw HTML omitted -->ð»å¾ä¸ºé»å·´å«©åªä½å¬å¸çé¨åé é¾ èã<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->#ä»¥åç©ºè¢­é»å·´å«©å¤å°è´275æ­»1024ä¼¤#<!-- raw HTML omitted --><!-- raw HTML omitted --> &lt;img style=&quot;&quot; src=&ldquo;<a href="https://tvax1.sinaimg.cn/large/639b1bfbgy1htyd2jzz2tj20zu12vwmc.jpg%22">https://tvax1.sinaimg.cn/large/639b1bfbgy1htyd2jzz2tj20zu12vwmc.jpg&quot;</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/5402554084/OykeUzfHd">éåº¦åªåæå®³å¥åº·ç[æ³ª] - è½¬å @é¡¶ç­TENä½¿:&amp;ensp;ä¹ä¿å²ç»ªé#ä¹ä¿å²ç»ªéææºå# 2024.09.22 20:29ãæ¬¸å¿å¿ãåååï½æ¯å¤©é½å¨åªåè½ç¶ææ¶åæç¹è¿åº¦åªåäºä½æ¯...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-09-23</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-5402554084-oykeuzfhd/">
    
    
    
    
    
      
    
    éåº¦åªåæå®³å¥åº·ç<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --> - è½¬å <!-- raw HTML omitted -->@é¡¶ç­TENä½¿<!-- raw HTML omitted -->:â<!-- raw HTML omitted --><!-- raw HTML omitted -->&lt;img style=&ldquo;width: 1rem;height: 1rem&rdquo; src=&ldquo;<a href="https://n.sinaimg.cn/photo/5213b46e/201">https://n.sinaimg.cn/photo/5213b46e/201</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/6015489225/OylW7xnJb">ä¹ä¿å²ç»ªé via.ä¹æ¨æ [å¾ç][å¾ç][å¾ç][å¾ç][å¾ç][å¾ç][å¾ç][å¾ç][å¾ç][å¾ç][å¾ç][å¾ç][å¾ç][å¾ç]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-09-23</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-6015489225-oylw7xnjb/">
    
    
    
    
    
      
    
    <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->ä¹ä¿å²ç»ªé<!-- raw HTML omitted --><!-- raw HTML omitted --> via.ä¹æ¨æ <!-- raw HTML omitted -->&lt;img style=&quot;&quot; src=&ldquo;<a href="https://tvax2.sinaimg.cn/large/006z6nxLgy1htxyd4qjjbj30hs0nqair.jp">https://tvax2.sinaimg.cn/large/006z6nxLgy1htxyd4qjjbj30hs0nqair.jp</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/6015489225/Oymgag7vp">ä¹ä¿å²ç»ªé#ä¹ä¿å²ç»ªéææºå# 2024.09.23 16:21ãå¥½åãæ©ä¸å¥½ä»æ©ä¸å°±å¼å§åªåå¦æè¿æè§æ»å¨å¬ãã¼ããã¤ãä¼¼ä¹æ¯å ä¸ºç§å¤©çæ¥ä¸´æå°ä¸èããè½ç¶è¿ä¹è¯´ï¼ä¼¼...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-09-23</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-6015489225-oymgag7vp/">
    
    
    
    
    
      
    
    <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->ä¹ä¿å²ç»ªé<!-- raw HTML omitted --><!-- raw HTML omitted -->&lt;a href=&ldquo;<a href="https://m.weibo.cn/search?containerid=231522type%3D1%26t%3D10%26q%3D%23%E4%B9%85%E4%BF%9D%E5%8F%B2%E7%BB%AA%E9%87%8C%E6%89%8B%E6%9C%25B">https://m.weibo.cn/search?containerid=231522type%3D1%26t%3D10%26q%3D%23%E4%B9%85%E4%BF%9D%E5%8F%B2%E7%BB%AA%E9%87%8C%E6%89%8B%E6%9C%B</a> &hellip;
    </a>
  </div>
</section>

</main>
</div>

<script async src="//yihui.name/js/center-img.js"></script>

<footer>

<div class="footer">
  <ul class="menu">
    
    <li><a href="/"><span data-hover="Home">Home</span></a></li>
    
    <li><a href="/about/"><span data-hover="About">About</span></a></li>
    
    <li><a href="/archives/"><span data-hover="Archive">Archive</span></a></li>
    
    <li><a href="/contributor/"><span data-hover="Contributor">Contributor</span></a></li>
    
    <li><a href="/index.xml"><span data-hover="Subscribe">Subscribe</span></a></li>
    
  </ul>
  
  <div class="copyright">Â© <a href="https://rainoffallingstar.github.io">Fallingstar</a> 2023 | <a href="https://github.com/rainoffallingstar">Github</a></div>
  
</div>
</footer>







</body>
</html>

